ERBB2 and breast carcinoma: The treatment strategies for breast cancer mainly include immunotherapy that targeting breast cancer-related genes, namely, nonspecific expression of human epidermal growth factor receptor (HER2), estrogen, or progesterone receptor and chemotherapy for triple-negative breast cancers (TNBCs).